Medical Properties Trust Stock Beneish M Score

MPW Stock  USD 4.87  0.03  0.62%   
This module uses fundamental data of Medical Properties to approximate the value of its Beneish M Score. Medical Properties M Score tells investors if the company management is likely to be manipulating earnings. The score is calculated using eight financial indicators that are adjusted by a specific multiplier. Please note, the M Score is a probabilistic model and cannot detect companies that manipulate their earnings with 100% accuracy. Check out Medical Properties Piotroski F Score and Medical Properties Altman Z Score analysis.
  
At this time, Medical Properties' Short and Long Term Debt Total is fairly stable compared to the past year. Net Debt is likely to climb to about 10.4 B in 2024, whereas Debt To Equity is likely to drop 0.94 in 2024. At this time, Medical Properties' Dividend Yield is fairly stable compared to the past year. Stock Based Compensation To Revenue is likely to climb to 0.04 in 2024, whereas PTB Ratio is likely to drop 0.37 in 2024.
At this time, it appears that Medical Properties Trust is an unlikely manipulator. The earnings manipulation may begin if Medical Properties' top management creates an artificial sense of financial success, forcing the stock price to be traded at a high price-earnings multiple than it should be. In general, excessive earnings management by Medical Properties executives may lead to removing some of the operating profits from subsequent periods to inflate earnings in the following periods. This way, the manipulation of Medical Properties' earnings can lead to misrepresentations of actual financial condition, taking the otherwise loyal stakeholders on to the path of questionable ethical practices and plain fraud.
-2.93
Beneish M Score - Unlikely Manipulator
Elasticity of Receivables

0.99

Focus
Asset Quality

0.96

Focus
Expense Coverage

1.67

Focus
Gross Margin Strengs

1.13

Focus
Accruals Factor

1.67

Focus
Depreciation Resistance

1.0

Focus
Net Sales Growth

0.63

Focus
Financial Leverage Condition

1.0

Focus

Medical Properties Beneish M-Score Indicator Trends

The cure to earnings manipulation is the transparency of financial reporting. It will typically remove the temptation of the top executives to inflate earnings (i.e., to promote the idea of 'winning at any cost'). Because a healthy internal audit department can enhance transparency, the board should promote the auditors' access to all the record-keeping systems across the enterprise. For example, if Medical Properties' auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back.
Current ValueLast YearChange From Last Year 10 Year Trend
Net Receivables424.2 M681 M
Way Down
Slightly volatile
Total Revenue549.6 M871.8 M
Way Down
Slightly volatile
Total Assets19.2 B18.3 B
Sufficiently Up
Slightly volatile
Total Current Assets1.3 B1.4 B
Notably Down
Slightly volatile
Non Current Assets Total17.8 B16.9 B
Sufficiently Up
Slightly volatile
Depreciation And Amortization646.9 M616.1 M
Sufficiently Up
Slightly volatile
Selling General Administrative152.9 M145.6 M
Sufficiently Up
Slightly volatile
Total Current Liabilities2.1 BB
Sufficiently Up
Slightly volatile
Non Current Liabilities Total9.1 B8.7 B
Sufficiently Up
Slightly volatile
Short Term Debt569.5 M463.1 M
Fairly Up
Slightly volatile
Long Term DebtB8.5 B
Sufficiently Up
Slightly volatile
Operating Income77.2 M81.3 M
Notably Down
Slightly volatile
Total Cash From Operating Activities287.9 M505.8 M
Way Down
Slightly volatile
Long Term Investments1.9 B3.3 B
Way Down
Slightly volatile
Gross Profit Margin1.080.9523
Moderately Up
Very volatile

Medical Properties Trust Beneish M-Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to detect the potential manipulation of earnings. Understanding the correlation between Medical Properties' different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Medical Properties in a much-optimized way. Analyzing correlations between earnings drivers directly associated with dollar figures is the most effective way to find Medical Properties' degree of accounting gimmicks and manipulations.

About Medical Properties Beneish M Score

M-Score is one of many grading techniques for value stocks. It was developed by Professor M. Daniel Beneish of the Kelley School of Business at Indiana University and published in 1999 under the paper titled The Detection of Earnings Manipulation. The Beneish score is a multi-factor model that utilizes financial identifiers to compile eight variables used to classify whether a company has manipulated its reported earnings. The variables are built from the officially filed financial statements to create a final score call 'M Score.' The score helps to identify companies that are likely to manipulate their profits if they show deteriorating gross margins, operating expenses, and leverage against growing revenue.

Other Operating Expenses

830.04 Million

At this time, Medical Properties' Other Operating Expenses is fairly stable compared to the past year.

Medical Properties Earnings Manipulation Drivers

Although earnings manipulation is typically not the result of intentional misconduct by the c-level executives, it is still a widespread practice by the senior management of public companies such as Medical Properties. It is usually done by a series of misrepresentations of various accounting rules and operating activities across multiple financial cycles. The best way to spot the manipulation is to examine the historical financial statement to find inconsistencies in earning reports to find trends in assets or liabilities that are not sustainable in the future.
201920202021202220232024 (projected)
Net Receivables910.4M1.4B2.1B1.2B681.0M424.2M
Total Revenue854.2M1.2B1.5B1.5B871.8M549.6M
Total Assets14.5B16.8B20.5B19.7B18.3B19.2B
Total Current Assets2.4B1.9B2.6B1.4B1.4B1.3B
Net Debt5.7B8.5B11.0B11.1B9.9B10.4B
Short Term Debt107.9M165.4M1.6B929.6M463.1M569.5M
Long Term Debt7.0B8.9B11.3B10.3B8.5B9.0B
Operating Income561.0M828.4M1.0B1.0B81.3M77.2M
Investments(53.2M)1.3B1.6B(139.9M)(114.9M)(109.2M)

About Medical Properties Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Medical Properties Trust's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medical Properties using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medical Properties Trust based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Medical Properties Trust is a strong investment it is important to analyze Medical Properties' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Medical Properties' future performance. For an informed investment choice regarding Medical Stock, refer to the following important reports:
Check out Medical Properties Piotroski F Score and Medical Properties Altman Z Score analysis.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for Medical Stock analysis

When running Medical Properties' price analysis, check to measure Medical Properties' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Properties is operating at the current time. Most of Medical Properties' value examination focuses on studying past and present price action to predict the probability of Medical Properties' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Properties' price. Additionally, you may evaluate how the addition of Medical Properties to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Is Medical Properties' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medical Properties. If investors know Medical will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medical Properties listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.49)
Dividend Share
0.88
Earnings Share
(0.93)
Revenue Per Share
1.48
Quarterly Revenue Growth
(0.13)
The market value of Medical Properties Trust is measured differently than its book value, which is the value of Medical that is recorded on the company's balance sheet. Investors also form their own opinion of Medical Properties' value that differs from its market value or its book value, called intrinsic value, which is Medical Properties' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medical Properties' market value can be influenced by many factors that don't directly affect Medical Properties' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medical Properties' value and its price as these two are different measures arrived at by different means. Investors typically determine if Medical Properties is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medical Properties' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.